Unity Biotechnology Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Unity Biotechnology, Inc. |
| Form Type | 10-K/A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, filing-update
TL;DR
Unity Bio filed an amendment to its 2024 10-K on April 11th. Check for updates.
AI Summary
Unity Biotechnology, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This amendment, filed on April 11, 2025, updates information previously submitted. The company, incorporated in Delaware with its principal executive offices at 285 East Grand Avenue, South San Francisco, CA, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and strategic direction.
Risk Assessment
Risk Level: low — This is an amendment to a previously filed annual report, not a new filing detailing significant new risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the amended annual report.)
- 2025-04-11 — Filing Date (The date this amendment was submitted to the SEC.)
Key Players & Entities
- Unity Biotechnology, Inc. (company) — Registrant
- 2024-12-31 (date) — Fiscal year end
- 2025-04-11 (date) — Filing date
- 285 East Grand Avenue, South San Francisco, CA 94080 (address) — Principal executive offices
- 001-38470 (company_id) — SEC File Number
FAQ
What is the purpose of this 10-K/A filing?
This is an amendment (Amendment No. 1) to the annual report for the fiscal year ended December 31, 2024, filed on April 11, 2025, to update previously submitted information.
What is Unity Biotechnology, Inc.'s fiscal year end?
Unity Biotechnology, Inc.'s fiscal year ends on December 31.
When was this amendment filed?
This amendment was filed on April 11, 2025.
Where are Unity Biotechnology, Inc.'s principal executive offices located?
Unity Biotechnology, Inc.'s principal executive offices are located at 285 East Grand Ave., South San Francisco, CA 94080.
What is the SEC file number for Unity Biotechnology, Inc.?
The SEC file number for Unity Biotechnology, Inc. is 001-38470.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 11, 2025 regarding Unity Biotechnology, Inc..